×
Back to Agenda
Frameworks for Digital Endpoints via the IND Pathway
Session Chair(s)
Megan Doyle, JD, MPH
Associate Vice President, Assistant General Counsel - Diagnostics, Eli Lilly and Company, United States
This panel will discuss current frameworks for digital endpoints that can be used by individual sponsors in their drug development programs, as well as remaining challenges for using digital tools to capture endpoint data.
Learning Objective : Discuss frameworks for digital endpoints that could be used by individual sponsors in their drug development programs; Describe current challenges in using digital tools to capture endpoint data and possible approaches to address this problem.
Speaker(s)
Elektra Papadopoulos, MD, MPH
Director, Patient Experience Data and Strategy, AbbVie, United States
Panelist
Lindsay Kehoe, MS
Senior Project Manager, Lead Emerging Programs, Clinical Trials Transformation Initiative (CTTI), United States
Panelist
Andrea Coravos
Chief Executive Officer, HumanFirst, United States
Panelist
Lauren Oliva, PHARMD, RPH
US Regulatory Policy Lead, Biogen, United States
Panelist
Have an account?